HomeUNCY • NASDAQ
add
Unicycive Therapeutics Inc
Previous close
$0.55
Day range
$0.58 - $0.62
Year range
$0.20 - $1.08
Market cap
71.96M USD
Avg Volume
785.34K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.99M | -13.21% |
Net income | 570.00K | 102.72% |
Net profit margin | — | — |
Earnings per share | -0.05 | 91.80% |
EBITDA | -7.98M | 13.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 19.77M | -59.60% |
Total assets | 27.95M | -46.65% |
Total liabilities | 16.68M | -45.60% |
Total equity | 11.27M | — |
Shares outstanding | 120.63M | — |
Price to book | 6.12 | — |
Return on assets | -67.00% | — |
Return on capital | -200.42% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 570.00K | 102.72% |
Cash from operations | -8.90M | -37.90% |
Cash from investing | -16.00K | -166.67% |
Cash from financing | 2.55M | -94.43% |
Net change in cash | -6.37M | -116.25% |
Free cash flow | -15.08M | -273.00% |
About
Founded
2016
Website
Employees
23
